Based on results from serial dilution sensitivity tests (eTable 2 in the Supplement), all ddPCR assays but 1 (ie, TP53 c.469G>T) were able to detect approximately 0.1% to 0.05% of tumor content with variable RA, depending on the starting tumor variated allele frequency. The gene discussed is TP53; the disease is neoplasm.